Pricing Log in Create free account

Biora Therapeutics, Inc. (BIORQ) vs GeoVax Labs Inc. (GOVX)

Biora Therapeutics, Inc. and GeoVax Labs Inc. are both Biotechnology companies. Biora Therapeutics, Inc. and GeoVax Labs Inc. are of similar size ($2.6M and $2.5M). GeoVax Labs Inc. grew revenue faster over the last twelve months: 963.6% against 347.0%. GeoVax Labs Inc. has the higher net margin (0.00% vs −3,527.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, GeoVax Labs Inc. leads on 9 and Biora Therapeutics, Inc. on 6.

Valuation

Metric BIORQ GOVX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.17 9.71
P/B n/m 0.60 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.08 0.64
EV/Sales 67.44 (0.27) 9.21
Earnings yield 0.00% (2,610.83%) (33.15%)
Free cash flow yield 0.00% (1,752.21%) (25.50%)

Profitability

Metric BIORQ GOVX Biotechnology median
Gross margin 85.79% 100.00% 65.16%
Operating margin (6,809.06%) 0.00% 0.00%
Net margin (3,527.85%) 0.00% 0.00%
Free cash flow margin (5,165.88%) 0.00% 0.00%
Return on equity 27.98% (891.59%) (56.36%)
Return on assets (128.19%) (408.79%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BIORQ GOVX Biotechnology median
Revenue growth (TTM) 347.00% 963.56% 6.02%
EPS growth (last fiscal year) (57.40%) 81.41% 30.26%
Revenue growth, 5-year CAGR (87.44%) 16.18% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIORQ GOVX Biotechnology median
Debt to equity (0.18) 0.00 0.00
Current ratio 0.05 1.54 4.72
Net debt to EBITDA (0.47) 0.14 0.96

Dividend

Metric BIORQ GOVX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BIORQ GOVX Biotechnology median
Market cap 2.49m 2.61m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack